GLP1R and obesity disorder: These results suggested that r-sFNDC5 possesses anti-obesity activity, similar to irisin (Xiong et al., 2015), and more importantly, these secreted FNDC5 derivatives may mediate the lipolysis effects of GLP-1 on adipose tissue.